Feasibility determination for use of polymerase chain reaction in the US Air Force air-transportable hospital field environment: Lessons learned

被引:5
作者
Niemeyer, DM [1 ]
Jaffe, RI [1 ]
Wiggins, LB [1 ]
机构
[1] USAF, Force Protect Battlelab, Lackland AFB, TX 78236 USA
关键词
D O I
10.1093/milmed/165.11.816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
At present, the use of molecular probes and polymerase chain reaction (PCR) for the identification of microorganisms in body fluids or tissues is becoming more commonplace. There is an added advantage when serological or culture methods are difficult, expensive, or unavailable. Slow-growing or fastidious microorganisms, including Mycobacterium tuberculosis, spirochetes, viruses, and the dimorphic fungi, can be detected rapidly using these techniques. The presence of different chromosomal or plasmid-mediated antibiotic-resistant markers can also be determined. PCR is an extremely powerful tool that has been applied to research, and more recently it has been used to augment standard clinical applications. It is a very simple process that can amplify nucleic acid sequences, both DNA and RNA, a million times over. The sensitivity, rapidity, broad applicability, and compactness of this technology make it an ideal candidate for use in the military arena. we recently established a molecular biology laboratory at a Deployable Medical System at the Camp Parks Army Reserve Training Facility in Dublin, California. This article will briefly summarize the use of PCR and its applicability in the air-transportable hospital field environment. Proper handling, processing, and testing as well as the requirements for setting up a molecular biology laboratory Will be discussed. Finally, the benefits and disadvantages of using PCR-based techniques in the deployed field environment will be considered.
引用
收藏
页码:816 / 820
页数:5
相关论文
共 25 条
[1]  
*AIR FORC OP TEST, 1999, FR99095 AIR FORC OP, P1
[2]  
Belgrader P, 1998, CLIN CHEM, V44, P2191
[3]  
*BETH RES LAB, 1984, FOCUS, V6, P7
[4]   Rapid, automated nucleic acid probe assays using silicon microstructures for nucleic acid concentration [J].
Christel, LA ;
Petersen, K ;
McMillan, W ;
Northrup, MA .
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME, 1999, 121 (01) :22-27
[5]  
DEMPSEY M, 1999, VIP OP HOUS NELL AIR
[6]  
HILYARD E, 1997, ANN M SAFMLS P, V21, P32
[7]  
IBRAHIM S, 1995, MCMRUIDR701Z US ARM
[8]  
*ID TECHN, 1999, RUGG ADV PATH ID DEV
[9]  
JONES E, 1999, ANN M SAFMLS P, V23, P37
[10]   p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma [J].
Koch, WM ;
Brennan, JA ;
Zahurak, M ;
Goodman, SN ;
Westra, WH ;
Schwab, D ;
Yoo, GH ;
Lee, DJ ;
Forastiere, AA ;
Sidransky, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1580-1586